Evidence map›Paper›PMID 36348747›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2022

Tailoring Screening Guidelines for Retinopathy of Prematurity in Egypt: An Exploratory Multicentric Study.

Ihab Abdel Aziz, Mohamed Fawzy Alsoda, Tarek Mohamed Elmenofy, Mohamed Medhat Sakhsoukh, Noha Mohamed Abd El Azim, Amr Mahmoud Ahmed, Sohaila Ali Abd El-Halim, Sherine Salaheldin Hassan Baris, Yousef Ahmed Fouad, Ayman Mohyieldin Elghonemy and 8 more

Open access · goldAbstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Ihab Abdel AzizDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.
Mohamed Fawzy AlsodaDepartment of Pediatrics and Neonatology, Ahmed Maher Teaching Hospital, Cairo, Egypt.
Tarek Mohamed ElmenofyDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.
Mohamed Medhat SakhsoukhDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.
Noha Mohamed Abd El AzimDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.
Amr Mahmoud AhmedDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.ORCID 0000-0002-3793-1138
Sohaila Ali Abd El-HalimDepartment of Pediatrics and Neonatology, Mataria Teaching Hospital, Cairo, Egypt.
Sherine Salaheldin Hassan BarisDepartment of Pediatrics and Neonatology, Mataria Teaching Hospital, Cairo, Egypt.
Yousef Ahmed FouadDepartment of Ophthalmology, Ain Shams University Hospitals, Cairo, Egypt.ORCID 0000-0002-2954-2917
Ayman Mohyieldin ElghonemyDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.
Heba MetwallyDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.
Wael Mohamed El GendyDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.ORCID 0000-0001-9142-7998
Raghdaa AliDepartment of Pediatrics and Neonatology, Ahmed Maher Teaching Hospital, Cairo, Egypt.
Yehia Mahmoud BashaDepartment of Pediatrics and Neonatology, Damanhour Teaching Hospital, Beheira, Egypt.
Eman Abo ElMaaty MohamedDepartment of Pediatrics and Neonatology, El-Galaa Teaching Hospital, Cairo, Egypt.
Wafaa Mohamed AminDepartment of Pediatrics and Neonatology, El-Galaa Teaching Hospital, Cairo, Egypt.
Maged Adly NaguibDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.
Hazem Abdallah ElnasharDepartment of Ophthalmology, The Memorial Institute for Ophthalmic Research, Giza, Egypt.
Research Institute of Ophthalmology · EGAin Shams University Hospital · EGDamanhour University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Retinopathy of prematurity (ROP) is increasing in incidence in developing nations, including Egypt. Secondary prevention requires timely detection through the development of regional screening guidelines, which should be preceded by large-scale studies to characterize the population at risk. Methods: A prospective, multicentric exploratory study that included five large tertiary institutions in an urban Egyptian setting. All infants born with gestational age (GA) < 37 weeks and/or birth weight (BW) ≤ 2000 grams were screened. More mature and heavier infants with unstable clinical course were also included. The primary outcome measure was the rate of ROP and high-risk disease occurrence in relation to underlying risk factors. Results: Of the 768 eyes (384 screened infants), 347 eyes (45.2%) had stage 1 or higher disease, and 43 eyes (5.6%) had high-risk disease. Eyes with stage 1 or higher ROP and treatment-requiring ROP had a mean (± SD) GA of 33.4 (± 2.6) weeks and 32.8 (± 3.2) weeks, and BW of 1842.3 (± 570.1) grams and 1747.6 ± (676.2) grams, respectively. Treatment-requiring eyes belonged to infants that had significantly lower GA and significantly higher prevalence of co-morbidities than non-treatment-requiring eyes. Conclusion: The incidence of ROP and high-risk disease in an urban Egyptian setting are similar to those in comparable settings elsewhere and locally. This exploratory study supports tailoring local screening criteria for ROP, and may aid the future development of national guidelines.

Indexed as

plus diseasepretermretinopathy of prematurityROPscreening

Identifiers

PMID36348747
PMCPMC9637363
OpenAlexW4308131111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.